Literature DB >> 11163020

Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease.

P Rocha-Pereira1, A Santos-Silva, I Rebelo, A Figueiredo, A Quintanilha, F Teixeira.   

Abstract

Psoriasis is a common chronic and recurrent inflammatory skin disorder that has been associated with oxidative stress, abnormal plasma lipid metabolism and with high frequency of cardiovascular events. This prevalence seems to be related to the severity of psoriasis, as it occurs more frequently in patients presenting large areas of the body affected with psoriasis lesions. The aim of our work was to evaluate the development of oxidative stress and of dislipidemia in psoriasis, and to look for a correlation between their levels and worsening of psoriasis. We evaluated lipid profile, total antioxidant capacity, antioxidant vitamins A and E, and lipoperoxidation products. The study was performed in controls and in patients presenting mild and severe psoriasis. Patients presented risk changes in lipid profile (a rise in cholesterol (P<0.01), triglycerides (P<0.001), low density lipoprotein cholesterol (P<0.01), very low density lipoprotein cholesterol (P<0.01), apolipoprotein B (P<0.001) and lipoprotein(a) (P<0.001); and a reduction in high density lipoprotein cholesterol (P<0.001)), a rise in lipoperoxidation products (P<0.001) and a reduction in total antioxidant capacity (P<0.001) and in antioxidant vitamins A (P<0.001) and E (P<0.05). Moreover, we found that the worsening of psoriasis was associated with the enhancement of oxidative stress and of the lipid risk changes. Our data suggest that psoriasis patients must be considered as a group at risk for cardiovascular disease and that this risk seems to be higher in severe psoriasis. In addition, a possible benefit of an enriched diet or of a supplement of vitamins A and E in psoriasis patients should be further studied.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11163020     DOI: 10.1016/s0009-8981(00)00358-2

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  49 in total

Review 1.  Metabolic disorders in patients with psoriasis and psoriatic arthritis.

Authors:  Lotus Mallbris; Christopher T Ritchlin; Mona Ståhle
Journal:  Curr Rheumatol Rep       Date:  2006-10       Impact factor: 4.592

2.  Metabolic Derangements in Lichen Planus - A Case Control Study.

Authors:  Bikash Ranjan Kar; Maitreyee Panda; Nibedita Patro
Journal:  J Clin Diagn Res       Date:  2016-11-01

3.  The Relationship between Lichen Planus and Carotid Intima Media Thickness.

Authors:  Koseoglu C; Erdogan M; Koseoglu G; Kurmus O; Ertem Ag; Efe Th; Kurmus Gi; Durmaz T; Keles T; Bozkurt E
Journal:  Acta Cardiol Sin       Date:  2016-11       Impact factor: 2.672

Review 4.  Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique background.

Authors:  Giulia Ganzetti; Anna Campanati; Elisa Molinelli; Annamaria Offidani
Journal:  World J Cardiol       Date:  2016-02-26

5.  Association of total oxidant status, total antioxidant status, and malondialdehyde and catalase levels with psoriasis: a systematic review and meta-analysis.

Authors:  YouCan Zhang; ZhongSheng Li; Yun Ma; Zhen Mu
Journal:  Clin Rheumatol       Date:  2019-07-18       Impact factor: 2.980

Review 6.  Lipid disturbances in psoriasis: an update.

Authors:  Aldona Pietrzak; Anna Michalak-Stoma; Grazyna Chodorowska; Jacek C Szepietowski
Journal:  Mediators Inflamm       Date:  2010-07-20       Impact factor: 4.711

7.  Is the Ratio of Antibodies Against Oxidized LDL to Oxidized LDL an Indicator of Cardiovascular Risk in Psoriasis?

Authors:  Medha Rajappa; Devinder Mohan Thappa; Laxmisha Chandrashekar; Malathi Munisamy; G Revathy
Journal:  Oman Med J       Date:  2016-09

8.  Altered redox status in the blood of psoriatic patients: involvement of NADPH oxidase and role of anti-TNF-α therapy.

Authors:  V V Barygina; M Becatti; G Soldi; F Prignano; T Lotti; P Nassi; D Wright; N Taddei; C Fiorillo
Journal:  Redox Rep       Date:  2013-04-19       Impact factor: 4.412

9.  Factors associated with the length of remission of psoriasis vulgaris.

Authors:  Susana Coimbra; Hugo Oliveira; Américo Figueiredo; Petronila Rocha-Pereira; Alice Santos-Silva
Journal:  Clin Drug Investig       Date:  2013-11       Impact factor: 2.859

10.  Psoriasis and cardiovascular risk factors: increased serum myeloperoxidase and corresponding immunocellular overexpression by Cd11b(+) CD68(+) macrophages in skin lesions.

Authors:  Lauren Y Cao; David C Soler; Sarah M Debanne; Ivan Grozdev; Myriam E Rodriguez; Rivka L Feig; Teresa L Carman; Robert C Gilkeson; Carl E Orringer; Elizabeth F Kern; Thomas S McCormick; Kevin D Cooper; Neil J Korman
Journal:  Am J Transl Res       Date:  2013-12-01       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.